PubRank

Gary P Jeffrey

Author PubWeight™ 37.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2004 4.40
2 Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005 2.99
3 Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology 2004 2.17
4 The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. Hepatology 2015 2.04
5 Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology 2009 1.54
6 Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007 1.49
7 Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 2009 1.44
8 Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection. J Med Virol 2003 1.09
9 Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome. Liver Int 2013 1.05
10 Assessing liver fibrosis with serum marker models. Clin Biochem Rev 2007 1.02
11 The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol 2015 1.02
12 Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011 1.01
13 Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection. J Med Virol 2002 0.97
14 Chylous ascites caused by portal vein thrombosis treated with octreotide. J Gastroenterol Hepatol 2003 0.96
15 The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients. Nephrol Dial Transplant 2009 0.92
16 Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand. HPB (Oxford) 2009 0.84
17 Octreotide in the treatment of refractory ascites of cirrhosis. Scand J Gastroenterol 2006 0.82
18 Clinical penetrance of C282Y homozygous HFE hemochromatosis. Expert Rev Hematol 2008 0.82
19 Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin. Immunol Cell Biol 2002 0.81
20 Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus disease. J Mol Histol 2009 0.81
21 Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2008 0.81
22 Clinical penetrance of C282Y homozygous HFE haemochromatosis. Clin Biochem Rev 2004 0.81
23 Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver Int 2013 0.80
24 Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation. Clin Transplant 2009 0.80
25 High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis. Clin Chem Lab Med 2013 0.80
26 Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population? J Gastroenterol Hepatol 2004 0.80
27 Hepatic iron loading in patients with compound heterozygous HFE mutations. Liver Int 2004 0.79
28 Oxidative stress causes a decline in lysosomal integrity during hypothermic incubation of rat hepatocytes. Free Radic Biol Med 2007 0.78
29 Late-onset carbamoyl phosphate synthetase 1 deficiency in an adult cured by liver transplantation. Liver Transpl 2011 0.77
30 Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report. Liver Transpl 2010 0.76
31 Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age. Ann Clin Biochem 2006 0.76
32 Desferrioxamine in warm reperfusion media decreases liver injury aggravated by cold storage. World J Gastroenterol 2013 0.75
33 Iron-induced oxidative rat liver injury after non-heart-beating warm ischemia is mediated by tumor necrosis factor α and prevented by deferoxamine. Liver Transpl 2014 0.75
34 Epstein-Barr virus-associated cholangiopathy: a new disease entity? Gastrointest Endosc 2006 0.75
35 Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease. J Clin Gastroenterol 2017 0.75
36 Expression of the HFE hemochromatosis gene in a community-based population of elderly women. J Gastroenterol Hepatol 2004 0.75